Standard Methotrexate Dosing in Children
Methotrexate dosing for children is primarily based on body surface area (BSA) in mg/m² or body weight in mg/kg, not chronological age. This accounts for growth differences without specific adjustments for age groups like infants versus adolescents.[1]
How Dosing Is Calculated for Pediatrics
- Low-dose oral/parenteral (e.g., juvenile idiopathic arthritis, JIA): 10-15 mg/m² weekly, or 15 mg/m² divided over 1-3 doses. Maximum single dose often capped at 20-25 mg to limit toxicity.[1][2]
- High-dose IV (e.g., cancer): 1,000-12,000 mg/m² depending on protocol, with leucovorin rescue.[1]
Renal function (via CrCl or eGFR) and folate supplementation guide adjustments more than age.[2]
Adjustments for Infants and Neonates
No strict age-based reductions, but preterm infants or neonates under 3 months may start at lower ends (e.g., 5-10 mg/m²) due to immature renal clearance and higher toxicity risk. Monitor closely for myelosuppression.[1][3]
Why Age Isn't the Main Factor
Children's pharmacokinetics scale with size; BSA normalizes exposure across ages 1-18. Age-related changes matter indirectly via organ maturity (e.g., slower clearance in <2 years).[2][3]
Common Reasons for Dose Changes
| Scenario | Adjustment |
|----------|------------|
| Renal impairment | Reduce by 50% if CrCl <50 mL/min/1.73m² [1] |
| Obesity | Use ideal body weight for BSA [2] |
| Toxicity (e.g., mucositis) | Hold or cut 25-50% [1] |
| Drug interactions (e.g., NSAIDs) | Lower dose or space out [2] |
Monitoring and Safety in Kids
Weekly blood counts, liver enzymes, and creatinine required. Age doesn't alter frequency, but younger kids (<5 years) face higher infection risk post-dose.[1][3]
Sources
[1]: Lexicomp - Methotrexate Pediatric Dosing
[2]: UpToDate - Methotrexate in Rheumatic Diseases in Children
[3]: Micromedex - Methotrexate